AN EXPERIMENTAL STUDY PERFORMED TO COMPARE THE HEPATOPROTECTIVE ACTIVITY OF ALOE VERA AND SILYMARIN IN CARBON TETRA CHLORIDE (CCL4)-INDUCED HEPATOTOXICITY IN ALBINO RABBITS

Author:

JAIN ANURAG,JAIN SUCHI,KOTHARI NITIN

Abstract

Objective: The aim of the study was to compare the hepatoprotective activity of Aloe vera and Silymarin in carbon tetrachloride (CCl4)-induced hepatotoxicity in albino rabbits. Methods: The study was conducted on 18 healthy albino rabbits of either sex weighing 1.5–2.0 kg, divided into three groups. Hepatotoxicity was induced in rabbits by administering CCl4(0.05 mg/kg) intraperitoneally. Alcoholic extracts of leaves of A. vera and Silymarin were administered orally for 20 days from day 1 to day 20 in the doses of 100mg/kg/day with the help of a syringe in groups II and III respectively. Results: Group I: There was an increase in the level of serum transaminase (p<0.001), serum alkaline phosphatase (p<0.001), serum bilirubin (p<0.001), and a decrease in serum albumin (p<0.001) due to hepatotoxic effect of CCl4 when compared to day 0 of the same group. Group II: A. vera extract was found to reduce the level of aspartate transaminase (p<0.0001), alanine transaminase (p<0.0001), serum alkaline phosphatase (p<0.0001), serum bilirubin (p<0.0001), and increase in serum albumin (p<0.0001). Group III: Silymarin was found to reduce the level of aspartate transaminase (p<0.0001), alanine transaminase (p<0.0001), serum alkaline phosphatase (p<0.0001), serum bilirubin (p<0.0001), and increase in serum albumin (p<0.0001). The findings of Group II and Group III were found to be statistically highly significant when compared with Group I. On histopathology, Group II showed maximum reduction in fatty changes compared to Group III. Conclusions: A. vera extract and Silymarin both showed a decline in hepatotoxic effects induced by CCl4. Comparatively, A. vera exhibited higher protection in restoration of liver function and regeneration of liver cells than Silymarin.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3